Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.

Stopped In accordance with protocol's predefined criteria and Data Monitoring Committee recommendation due to insufficient level of efficacy

Conditions

• Malaria

Interventions

• DRUG: SAR97276A

Sponsor

Sanofi